Harel Insurance Investments & Financial Services Ltd. Novo Cure LTD Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$11.83 - $24.05 $2,070 - $4,208	-175 Reduced 16.46%	888 $15,000
Q1 2024 Apr 30, 2024	SELL	$12.42 - $17.29 $3,763 - $5,238	-303 Reduced 22.18%	1,063 $17,000
Q4 2023 Jan 30, 2024	SELL	$11.13 - $15.78 $2,582 - $3,660	-232 Reduced 14.52%	1,366 $20,000
Q3 2023 Oct 30, 2023	BUY	$16.15 - $42.35 $12,403 - $32,524	768 Added 92.53%	1,598 $26,000
Q2 2023 Jul 17, 2023	SELL	$40.29 - $82.51 $25,785 - $52,806	-640 Reduced 43.54%	830 $34,000
Q1 2023 May 02, 2023	BUY	$56.44 - $118.81 $36,686 - $77,226	650 Added 79.27%	1,470 $88,000
Q4 2022 Jan 26, 2023	SELL	$63.98 - $85.37 $7,677 - $10,244	-120 Reduced 12.77%	820 $60,000
Q3 2022 Oct 31, 2022	SELL	$67.99 - $89.57 $4,555 - $6,001	-67 Reduced 6.65%	940 $72,000
Q2 2022 Jul 19, 2022	SELL	$56.6 - $89.9 $27,507 - $43,691	-486 Reduced 32.55%	1,007 $70,000
Q1 2022 May 03, 2022	SELL	$60.15 - $84.52 $33,804 - $47,500	-562 Reduced 27.35%	1,493 $124,000
Q4 2021 Feb 07, 2022	BUY	$75.08 - $121.99 $154,289 - $250,689	2,055 New	2,055 $164,000
Q3 2020 Oct 20, 2020	SELL	$58.05 - $111.31 $116,100 - $222,620	-2,000 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$57.2 - $74.41 $114,400 - $148,820	2,000 New	2,000 $119,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$215 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$210 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$140 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$76.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$53.7 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account